Prebiotics, probiotic nutrients and functional food - Dietary modulation of the gut microbiota;Präbiotika, probiotische nahrungsmittel und functional food - Diätetische modulation der darmflora

Verdauungskrankheiten

Volumn 26, Issue 4, 2008, Pages 161-170

  Leiss O ^a   Lutz Vorderbrugge A ^a   Clement, T ^a   Borner, N ^a   Godderz W ^a  

^a Gastroenterologische Gemeinschaftspraxis   (Germany)

Author keywords

Dietary modulation of microbiota; Functional food; Prebiotics; Soluble fiber; Yoghurt

Indexed keywords

MONOSACCHARIDE; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ALLERGIC DISEASE; BACTERIAL GROWTH; BIFIDOBACTERIACEAE; CALCIUM ABSORPTION; CANCER PREVENTION; COLON CANCER; DIETARY FIBER; FUNCTIONAL FOOD; HEPATIC ENCEPHALOPATHY; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LIPID METABOLISM; MOLECULAR WEIGHT; REVIEW;

EID: 51449122316     PISSN: 0174738X     EISSN: None     Source Type: Journal    
DOI: 10.5414/vdp26161     Document Type: Review

References (52)

1. Anderson JW, Floore TL, Geil PB et al. Hypocholestrolemic effects of different hydrophilic fibres. Arch Intern Med. 1991; 151: 1597-1602.
2. Ballonge J, Schumann C, Quignon P. Effects of lactulose and lactilol on colonic microflora and enzymatic activities. Scand J Gastroenterol. 1997; 32 (Suppl): 41-44.
3. Bischoff SC, Manns MP. Probiotika. Präbiotika und Synbiotika - Stellenwert in Klinik und Praxis. Dtsch Ärztebl. 2005; 102: A752-759.
4. Cashman K. Prebiotics and calcium bioavailability. In: Tannock GW (ed). Probiotics and prebiotics: where are we going? Wymondham, England: Caister Academic Press; 2002, 149-174.
5. Coudray C, Bellanger J, Castiglia-Delavaud C et al. Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men. Euro J Clin Nutr. 1997; 51: 375-380.
6. Cummings JH, Macfarlane GT, Englyst HN. Prebiotic digestion and fermentation. Am J Clin Nutr. 2001; 73 (Suppl): 415-429.
7. Dasarathy S, Mullen KD. Therapy of porto-systemic encephalopathy. In: Wolfe MM (ed). Therapy of digestive disorders. A Companion to Sleisengcr and Fordtran's Gastrointestinal and Liver Disease. Philadelphia: WB Saunders Company; 2000, 385-397.
8. Delzenne NM, Kok NN. Biochemical basis of oligofructose-induced hypolipidaemia in animal models. J Nutr. 1999; 129: 1467-1470.
9. Duggan C, Gannon J, Walker WA. Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr. 2002; 75: 789-808.
10. Elmer GW, McFarland LV, McFurland M. The power of probiotics improving your health with beneficial microbes. New York: The Haworth Press: 2007, 189-200.
11. Fairweather-Tait SJ, Johnson IT. Bioavailability of minerals. In: Gibson GR, Roberfroid MB (eds). Colonic microbiota, nutrition and health. Dordrecht: Kluwer Academic Press, 1999.
12. Floch MH. Prebiotics, probiotics, and dietary fiber. In: Buchman AL (ed). Clinical nutrition in gastrointestinal disease. Thorofare, USA: SLACK Incorporated; 2006, 123-138.
13. Garcia-Tsao G, Wiest R. Gut microflora in the pathogenesis of complications of cirrhosis. Best Practice & Research Clinical Gastroenterology. 2004; 18: 353-372.
14. Gibson GR, Beatty ER, Wand X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. 1995; 108: 975-982.
15. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995; 125: 1401-1412.
16. Greger JL. Nondigestible carbohydrates and mineral bioavailability. J Nutr. 1999; 129: 1434-1435.
17. Guarner F, Bourdet-Sicard R, Brandtzaeg P et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 2006; 3: 275-284.
18. Guarner F. Hygiene, microbial diversity and immune regulation. Curr Opin Gastroenterol. 2007; 23: 667-672.
19. Hamer HM, Jonkers D, Venema K et al. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008; 27: 104-119.
20. Heaver P, Rowland IR. Gastrointestinal cancer. Best Practice & Research Clinical Gastroenterology. 2004; 18: 323-336.
21. Hill MJ, Draser BS, Hawksworth G et al. Bacteria and aetiology of cancer of the large bowel. Lancet. 1971; 1: 95-100.
22. Huth K, Burkhard M. Ballaststoffe - Chemie, physiologische Wirkungen, gesundheitlicher Wert, Ballaststoffzufuhr und Kostpläne. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2004.
23. Jaskari J, Kontula P, Siitonen A et al. Oat β-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains. Applied Microbiology and Biotechnology. 1998; 49: 175-181.
24. Jenkins DJA, Newton AC, Leeds AR, Cummings JH. Effect of pectin, guar gum, and wheat fibre on serum cholesterol. Lancet. 1975; 1: 116-117.
25. Kalliomäki M, Salminen S, Kero P et al. Probiotics in the primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001; 357: 1076-1079.
26. Kalliomäki M, Salminen S, Poussa T et al. Probiotics and prevention of atopic disease - a 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003; 361: 1869-1870.
27. Kim Y-I. AGA technical review. Impact of dietary fiber on colon cancer occurrence. Gastroenterology. 2000; 118: 1235-1257.
28. Kim Y-I. Nutrition and colorectal cancer. In: Buehman AL (ed). Clinical nutrition in gastrointestinal disease. Thorofare, USA: SLACK Incorporated; 2006, 205-223.
29. Kromhout D, Bosschieter EB, Coulander C et al. Dietary fibre and 10-year mortality from coronary heart disease, cancer, and all causes. Lancet. 1982: 1: 518-522.
30. Leitzmann C, Müller C, Michel P, Brehme U, Hahn A, Laube H. Ernährung in Prävention und Therapie. Kapitel: Nahrungsergä nzungsmittel und Functional Food. Stuttgart: Hippokrates Verlag; 2001, 94-105.
31. Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ. 1999; 318: 999-1003.
32. Manning TS, Gibson GR. Prebiotics. Best Practice & Research Clinical Gastroenterology. 2004; 18: 287-298.
33. McCullough AJ. Nutritional therapy in liver disease. In: Wolfe MM (ed). Therapy of digestive disorders. A Companion to Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Philadelphia: WB Saunders Company; 2000, 448-464.
34. Mc Farland LV. Quality control and regulatory issues for biotherapeutic agents. In: Elmer GW, McFarland LV, Surawicz CM (eds). Biotherapeutic agents and infectious diseases. Totowa, NJ: Humana Press; 1999, 1-26.
35. Metchnikoff E. The prolongation of life. New-York: Putman and Sons; 1908.
36. Okazaki M, Fujikawa S, Matsumoto N. Effects of xylooligosaccharide on growth of bifidobacteria. J Jap Nutr Food Sci. 1990; 43: 395-401.
37. Olsen BH, Anderson SM, Becker MP et al. Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results for a meta-analysis. J Nutr. 1997; 127: 1973-1980.
38. Ouwehand AC, Isolauri E, He F et al. Differences in bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunology. 2001; 108: 144-145.
39. Pereira DI, Gibson GR. Effect of consumption of probiotics and prebiotics on serum lipid levels in humans. Critical Reviews in Biochemistry and Molecular Biology. 2002; 37: 259-281.
40. Pereira MA, O'Reilly E, Augustsson K et al. Dietary fiber and risk of coronary heart disease. Arch Intern Med. 2004; 164: 370-376.
41. Pool-Zobel BL. Inulin-type fruetans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr. 2005; 93: 73-90.
42. Rafter J. The role of lactic acid bacteria in colon cancer prevention. Scand J Gastroenterol. 1995; 30: 497-502.
43. Ready BS. Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies. Brit J Nutr. 1998; 80: 219-223.
44. Riggio O, Varriale M, Testore GP et al. Effect of lactilol and lactulose administration on the fecal flora in cirrhotic patients. J Clin Gastroenterol. 1990; 12: 433-436.
45. Salminen S, Bouley C, Boutron-Ruault M-C et al. Functional food science and gastrointestinal physiology and function. Brit J Nutr. 1998; 80: 147-171.
46. Schloz-Ahrens KE, Ade P, Marten B et al. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr. 2007; 137: 838-846.
47. Southgate D, Englyst H. Dietary fibre: chemistry, physical properties and analysis. In: Trowell H, Burkitt D, Heaton K (eds). Dietary fibre, fibre-depleted foods and disease. London: Academic Press; 1985, 31-55.
48. Uribe M, Marquez MA, Garcia-Ramos G et al. Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients. Dig Dis Sci. 1980; 25: 924-928.
49. van den Heuvel F, Schaafsma G, Muys T, van Dokkum W. Non-digestible oligosaccharides do not interfere with calcium and non-haeme iron absorption in young, healthy men. Am J Clin Nutr. 1998; 67: 445-451.
50. van den Heuvel F, Muys T, van Dokkum W, Schaafsma G. Oligofructose stimulates calcium absorption in adolescents. Am J Clin Nutr. 1999; 69: 544-548.
51. World Cancer Research Found. Food, nutrition and the prevention of cancer: a global perspective. Washington DC: American Institute for Cancer Research; 1997.
52. Zunft H-JF. Funktionelle Lebensmittel. In: Schauder P, Ollenschläger G (Hrsg). Ernährungsmedizin - Prävention und Therapie. 3., völlig überarbeitete und erweiterte Auflage. München: Urban & Fischer; 2006, 175-184.